Related Experiment Videos
[A case report of cavernous hemangioma of the left atrial epicardium]
T Hara1, T Ushijima, H Takemura
1Department of Surgery (I), Kanazawa University School of Medicine, Japan.
Insights
A rare cardiac hemangioma in the left atrium was successfully resected in a 44-year-old woman. This benign vascular tumor did not recur, and the patient recovered well three years post-operation.
Area of Science:
- Cardiovascular Medicine
- Surgical Oncology
Background:
- Cardiac hemangiomas are rare, benign vascular tumors.
- Atrial fibrillation can be a rare symptom of cardiac tumors.
Observation:
- A 44-year-old woman presented with a left atrial hemangioma and transient atrial fibrillation.
- Imaging revealed a hypervascular tumor with clear borders in the pericardial cavity.
- Coronary angiography identified feeding arteries from the right and left circumflex coronary arteries.
Findings:
- The pericardial tumor was surgically resected under cardiopulmonary bypass.
- Pathological examination confirmed a cavernous hemangioma.
- No recurrence was observed three years post-surgery.
Implications:
- Complete surgical resection is an effective treatment for cardiac hemangioma.
- Long-term follow-up confirms favorable outcomes after resection.
- This case highlights the importance of considering rare cardiac tumors in the differential diagnosis of arrhythmias.
Abstract:
Cardiac hemangioma is a rare benign vascular tumor. A 44-year-old woman with hemangioma arising from the left atrium and transient atrial fibrillation is reported. Echocardiography, computed tomography and magnetic resonance imaging suggested a hypervascular tumor with clear borders in the pericardial cavity. Selective coronary angiography demonstrated feeding arteries arising from the right and left circumflex coronary arteries. Under cardiopulmonary bypass the tumor was successfully resected. Pathological examination showed a cavernous hemangioma. There is no evidence of recurrence and the patient is doing well three years after the operation.